Dische S, Saunders M I, Flockhart I R
Br J Cancer Suppl. 1978 Jun;3:318-21.
The amount of misonidazole which may be given to one patient is limited because of the risk of neurotoxicity. The drug may be given with every treatment of a multi-fraction course of radiotherapy or only with some of the treatments. The number of radiotherapy treatments can be reduced or multiple treatments given after each dose of the drug. Experience in 19 patients given daily doses of misonidazole is reported. This is practical regime to be considered for clinical trials of this hypoxic cell sensitizer.
由于存在神经毒性风险,给予单个患者的米索硝唑剂量是有限的。该药物可在多疗程放射治疗的每次治疗时给予,或仅在部分治疗时给予。放射治疗的次数可以减少,或者在每次给药后进行多次治疗。报告了19例每日给予米索硝唑患者的经验。这是在对这种乏氧细胞增敏剂进行临床试验时可考虑的实用方案。